ADVERUM BIOTECHNOLOGIES INC's ticker is ADVM and the CUSIP is 00773U108. A total of 95 filers reported holding ADVERUM BIOTECHNOLOGIES INC in Q1 2022. The put-call ratio across all filers is 0.25 and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q1 2022 | $15,000 | -28.6% | 11,117 | -5.3% | 0.00% | – |
| Q4 2021 | $21,000 | -50.0% | 11,743 | -39.4% | 0.00% | – |
| Q3 2021 | $42,000 | -63.2% | 19,364 | -40.5% | 0.00% | – |
| Q2 2021 | $114,000 | -70.5% | 32,528 | -16.9% | 0.00% | – |
| Q1 2021 | $386,000 | -10.4% | 39,153 | -1.6% | 0.00% | – |
| Q4 2020 | $431,000 | +53.4% | 39,799 | +46.0% | 0.00% | – |
| Q3 2020 | $281,000 | -50.8% | 27,261 | -0.4% | 0.00% | -100.0% |
| Q2 2020 | $571,000 | +476.8% | 27,359 | +171.3% | 0.00% | – |
| Q1 2020 | $99,000 | -13.9% | 10,083 | -54.2% | 0.00% | – |
| Q1 2019 | $115,000 | +66.7% | 22,024 | +1.0% | 0.00% | – |
| Q4 2018 | $69,000 | -72.3% | 21,801 | -47.0% | 0.00% | – |
| Q3 2018 | $249,000 | +16.4% | 41,128 | +1.9% | 0.00% | – |
| Q2 2018 | $214,000 | – | 40,361 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| BML Capital Management, LLC | 3,915,000 | $5,872,500 | 5.39% |
| Versant Venture Management, LLC | 5,068,233 | $7,602,350 | 4.04% |
| Sonic GP LLC | 2,000,000 | $3,000,000 | 2.91% |
| COMMODORE CAPITAL LP | 10,000,000 | $15,000,000 | 1.75% |
| VR Adviser, LLC | 6,573,300 | $9,859,950 | 1.04% |
| AIGH Capital Management LLC | 1,323,985 | $1,985,977 | 0.94% |
| Newtyn Management, LLC | 1,025,000 | $1,537,500 | 0.38% |
| Worth Venture Partners, LLC | 331,668 | $497,502 | 0.30% |
| Acuitas Investments, LLC | 291,169 | $436,754 | 0.26% |
| Quinn Opportunity Partners LLC | 398,298 | $597,447 | 0.08% |